Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 12;40(52):7646-7652.
doi: 10.1016/j.vaccine.2022.10.080. Epub 2022 Nov 7.

Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study

Affiliations

Occupation, Worker Vulnerability, and COVID-19 Vaccination Uptake: Analysis of the Virus Watch prospective cohort study

Sarah Beale et al. Vaccine. .

Abstract

Background: Occupational disparities in COVID-19 vaccine uptake can impact the effectiveness of vaccination programmes and introduce particular risk for vulnerable workers and those with high workplace exposure. This study aimed to investigate COVID-19 vaccine uptake by occupation, including for vulnerable groups and by occupational exposure status.

Methods: We used data from employed or self-employed adults who provided occupational information as part of the Virus Watch prospective cohort study (n = 19,595) and linked this to study-obtained information about vulnerability-relevant characteristics (age, medical conditions, obesity status) and work-related COVID-19 exposure based on the Job Exposure Matrix. Participant vaccination status for the first, second, and third dose of any COVID-19 vaccine was obtained based on linkage to national records and study records. We calculated proportions and Sison-Glaz multinomial 95% confidence intervals for vaccine uptake by occupation overall, by vulnerability-relevant characteristics, and by job exposure.

Findings: Vaccination uptake across occupations ranged from 89-96% for the first dose, 87-94% for the second dose, and 75-86% for the third dose, with transport, trade, service and sales workers persistently demonstrating the lowest uptake. Vulnerable workers tended to demonstrate fewer between-occupational differences in uptake than non-vulnerable workers, although clinically vulnerable transport workers (76%-89% across doses) had lower uptake than several other occupational groups (maximum across doses 86%-96%). Workers with low SARS-CoV-2 exposure risk had higher vaccine uptake (86%-96% across doses) than those with elevated or high risk (81-94% across doses).

Interpretation: Differential vaccination uptake by occupation, particularly amongst vulnerable and highly-exposed workers, is likely to worsen occupational and related socioeconomic inequalities in infection outcomes. Further investigation into occupational and non-occupational factors influencing differential uptake is required to inform relevant interventions for future COVID-19 booster rollouts and similar vaccination programmes.

Keywords: COVID-19; Occupation; SARS-CoV-2; Vaccination uptake.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interests The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [AH serves on the UK New and Emerging Respiratory Virus Threats Advisory Group and is a member of the COVID-19 transmission sub-group of the Scientific Advisory Group for Emergencies (SAGE). The other authors report no conflicts of interest.].

Figures

Fig. 1
Fig. 1
Proportions and 95% Confidence Intervals for Vaccination Status by Occupation for First Dose (i), Second Dose (ii), and Third Dose (iii).
Fig. 2
Fig. 2
Proportions and 95% Confidence Intervals for Vaccination Status by Occupation, Stratified by Clinical Vulnerability for First Dose (i), Second Dose (ii), and Third Dose (iii).

References

    1. McDonald I, Murray SM, Reynolds CJ, Altmann DM, Boyton RJ. Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2. npj Vaccines. 2021 May 13;6(1):1–14. - PMC - PubMed
    1. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022 Jan 1;114:252–60. - PMC - PubMed
    1. Beale S, Patel P, Rodger A, Braithwaite I, Byrne T, Fong WLE, et al. Occupation, Work-Related Contact, and SARS-CoV-2 Anti-Nucleocapsid Serological Status: Findings from the Virus Watch prospective cohort study. medRxiv. 2021 May 18;2021.05.13.21257161. - PMC - PubMed
    1. Europe. 2022 May;1(16)
    1. Latsuzbaia A., Herold M., Bertemes J.P., Mossong J. Evolving social contact patterns during the COVID-19 crisis in Luxembourg. PLoS ONE. 2020 Aug 6;15(8):e0237128. - PMC - PubMed

Publication types

Substances